These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16188519)

  • 1. B-type natriuretic peptide as an alternative way of assessing total cardiovascular risk in patients with diabetes mellitus.
    Dawson A; Jeyaseelan S; Morris AD; Struthers AD
    Am J Cardiol; 2005 Oct; 96(7):933-4. PubMed ID: 16188519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac risk scores in high-risk Hispanics and the predictive value of BNP.
    Macabasco-O'Connell A; Danwalder S; Sinha K
    J Clin Nurs; 2011 Nov; 20(21-22):3039-46. PubMed ID: 21592244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
    J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can measurement of B-type natriuretic peptide levels improve cardiovascular disease prevention?
    Campbell DJ
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):442-6. PubMed ID: 18307738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients.
    Toussaint ND; Polkinghorne KR; Kerr PG
    Hemodial Int; 2008 Apr; 12(2):254-63. PubMed ID: 18394060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
    Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of B-type natriuretic peptide levels with clinical data and exercise testing for predicting coronary artery disease.
    Wolber T; Maeder M; Weilenmann D; Duru F; Bluzaite I; Riesen W; Rickli H; Ammann P
    Am J Cardiol; 2006 Sep; 98(6):764-7. PubMed ID: 16950181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide is predictive of hospitalization in community-dwelling elderly without heart diseases.
    Shimizu Y; Nishinaga M; Takata J; Miyano I; Okumiya K; Matsubayashi K; Ozawa T; Yasuda N; Doi Y
    Geriatr Gerontol Int; 2009 Jun; 9(2):148-54. PubMed ID: 19740358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
    Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
    Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption.
    Maeder MT; Brutsche MH; Staub D; Morgenthaler NG; Bergmann A; Noveanu M; Laule K; Breidthardt T; Christ A; Klima T; Reichlin T; Potocki M; Mueller C
    J Intern Med; 2009 May; 265(5):604-15. PubMed ID: 19226375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
    Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study.
    Nakamura M; Tanaka F; Sato K; Segawa T; Nagano M
    J Card Fail; 2005 Dec; 11(9):705-12. PubMed ID: 16360967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes.
    Atwater BD; Milford-Beland S; Newby LK; Hernandez AF; Peacock WF; Gibler WB; Christenson RH; Ohman EM; Peterson ED; Roe MT
    Am J Cardiol; 2007 Dec; 100(12):1727-33. PubMed ID: 18082516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.